Srilatha Edupuganti MD
[Pronunciation: Sri]
Professor, Medicine, Emory University School of Medicine
Join to View Full Profile
80 Jesse Hill Jr Dr SEAtlanta, GA 30303
Phone+1 404-778-7717
Dr. Edupuganti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North CarolinaMPH, Epidemiology, 2005
Emory University School of MedicineFellowship, Infectious Disease, 1995 - 1997
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1992 - 1995
Louisiana State University School of Medicine in New OrleansClass of 1992
Certifications & Licensure
GA State Medical License 1995 - 2027
NC State Medical License 1997 - 2018
LA State Medical License 1994 - 1995
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- HVTN Citizenship Award HIV vaccine trials network, 2019
- Paper of the year International Society of Vaccines, 2017
- Member of Alpha Omega Alpha Honor Medical Society 1992
Clinical Trials
- Human Immune Responses to Yellow Fever Vaccination
- Measles, Mumps, and Rubella (MMR) Immunity in College Students Start of enrollment: 2010 Mar 01
- Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine Start of enrollment: 2019 Apr 15
- Join now to see all
Publications & Presentations
PubMed
- The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteins.Sanjeev Kumar, Shilpi Jain, Bushra Wali, Veronika I Zarnitsyna, Devyani Joshi
Science Translational Medicine. 2025-09-03 - Regulation of CD45 isoforms during human effector and memory CD8 T cell differentiation: Implications for T cell nomenclature.Donald J McGuire, Rama S Akondy, Shu Yang, Srilatha Edupuganti, Shashi Nagar
Proceedings of the National Academy of Sciences of the United States of America. 2025-08-12 - 7 citationsVaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.Jordan R Willis, Madhu Prabhakaran, Michelle Muthui, Ansuya Naidoo, Troy Sincomb
Science. 2025-07-31
Press Mentions
Emory University Participating in First-of-Its-Kind HIV Vaccine TrialJuly 21st, 2022- Emory Participating in Trial to Test mRNA HIV Vaccine in HumansJune 7th, 2022
- The Only Way We’ll Know When We Need COVID-19 BoostersJune 23rd, 2021
- Join now to see all
Grant Support
- A Phase 2b randomized open label trial to assess the quality and balance of dengue immunity elicited by prime-boost combinations of TAK-003 and Butantan-DVEMORY UNIVERSITY2025–2030
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
